CDC, PE firm float pharma platform, buy Sequoia-backed drugmaker

Premium

CDC Group Plc and a private equity firm have set up a pharmaceuticals platform that is acquiring a Sequoia Capital-backed Indian drugmaker in one of its first bets, a person familiar with the development told VCCircle. The British development finance institution and Africa-focused Development Partners International (DPI) have floated Zanzibar Pharma ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.